Gross Profit Margin (Quarterly) Chart

Historical Gross Profit Margin (Quarterly) Data

View and export this data back to 2003. Start Trial.
Date Value
June 30, 2026 78.37%
March 31, 2026 48.70%
December 31, 2025 78.81%
September 30, 2025 68.85%
June 30, 2025 80.54%
March 31, 2025 81.81%
December 31, 2024 73.52%
September 30, 2024 78.05%
June 30, 2024 78.21%
March 31, 2024 75.59%
December 31, 2023 72.62%
September 30, 2023 74.77%
June 30, 2023 73.30%
March 31, 2023 67.90%
December 31, 2022 71.22%
September 30, 2022 74.12%
June 30, 2022 73.32%
March 31, 2022 62.03%
December 31, 2021 67.28%
September 30, 2021 67.13%
June 30, 2021 67.75%
March 31, 2021 63.40%
December 31, 2020 66.04%
September 30, 2020 64.49%
June 30, 2020 65.30%
Date Value
March 31, 2020 61.33%
December 31, 2019 71.46%
September 30, 2019 61.27%
June 30, 2019 64.73%
March 31, 2019 56.01%
December 31, 2018 61.65%
September 30, 2018 62.96%
June 30, 2018 62.46%
March 31, 2018 58.67%
December 31, 2017 63.78%
September 30, 2017 66.57%
June 30, 2017 66.51%
March 31, 2017 51.24%
December 31, 2016 65.82%
September 30, 2016 67.91%
June 30, 2016 67.79%
March 31, 2016 64.50%
December 31, 2015 68.27%
September 30, 2015 68.81%
June 30, 2015 68.98%
December 31, 2014 63.07%
September 30, 2014 66.70%
June 30, 2014 66.25%
December 31, 2013 65.58%
September 30, 2013 68.64%

Gross Profit Margin Definition

Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.

Read full definition.

Gross Profit Margin (Quarterly) Range, Past 5 Years

View Gross Profit Margin (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Gross Profit Margin (Quarterly) Benchmarks

View Gross Profit Margin (Quarterly) Benchmarks
Start Trial
AstraZeneca PLC 76.09%
Takeda Pharmaceutical Co., Ltd. 57.57%
Ono Pharmaceutical Co., Ltd. 75.31%
Shionogi & Co., Ltd. 71.45%
Astellas Pharma, Inc. 75.29%

Gross Profit Margin (Quarterly) Related Metrics